Second Quarter Results Second Quarter Net Sales Growth Overview (1) (1) (1) (1) Sales Analysis Earnings Analysis 2024 Outlook 1 As previously announced, we will host a conference call on Tuesday, July 30, 2024 at 4:30 p.m., Eastern Time, to discuss our operating results for the quarter ended June 30, 2024 and provide an operational update. Please register for this conference call at: https://www.veracast.com/webcasts/stryker/events/SYK2Q24.cfm. After registering, a confirmation will be sent via email, inclu ...

Q Guidance System with Spine Guidance 5 Software featuring Copilot is a first-to-market technology, pioneering new planning and surgical capabilities Q Guidance System with Spine Guidance 5 Software featuring Copilot is a first-to-market technology, pioneering new planning and surgical capabilities. Q Guidance System with Spine Guidance 5 Software featuring Copilot is a first-to-market technology, pioneering new planning and surgical capabilities. "This project is a prime example of our mission in action," ...

The collective assessment of analysts points to an estimated 'Net Sales by Geography- Orthopaedics and SpineHips- International' of $150.28 million. The estimate indicates a year-over-year change of +4.4%. View all Key Company Metrics for Stryker here>>> Over the past month, shares of Stryker have returned -3.9% versus the Zacks S&P 500 composite's -1.2% change. Currently, SYK carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see th ...

More on the News Stryker has been following an acquisition-driven strategy to boost its growth profile. In 2023, the company acquired several companies to increase its offerings. These include Cerus, which designs, develops and manufactures neurovascular products used for the treatment of hemorrhagic stroke. The business has been integrated with Stryker's Neurovascular business. Industry Prospects Notable Developments For year-to-date period, SYK shares have rallied 9.7% compared with the industry's rise of ...

Stryker Corporation (SYK) witnessed substantial gains in the year-to-date period. Shares of the company have rallied 11.6% compared with 1.7% growth of the industry. The S&P 500 Composite has risen 17.5% during the same time frame. With healthy fundamentals and strong growth opportunities, this Zacks Rank #2 (Buy) company appears to be a solid wealth creator for its investors at the moment. Headquartered in Kalamazoo, MI, Stryker is one of the world's largest medical device companies operating in the global ...

About Stryker For investor inquiries please contact: Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or jason.beach@stryker.com For media inquiries please contact: Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or yin.becker@stryker.com Stryker will host a webcast at 4:30pm ET on Tuesday, July 30, to discuss results for its second quarter fiscal year 2024. The webcast can be accessed at Stryker - Events & Presentations. An archive of the webcast will ...

Founded in 1994, IRCAD opened its first facility on the grounds of the University Hospital of Strasbourg, France, and currently has training centers in seven countries: Brazil, China, France, India, Lebanon, Rwanda and Taiwan. When it opens in the summer of 2025, IRCAD NA, in Charlotte, will be its exclusive training headquarters in North America. Media contact Jeanine Guilfoyle Director, Communications, Stryker [email protected] PORTAGE, Michigan and CHARLOTTE, North Carolina, USA, June 18, 2024 /PRNewswir ...

More on LIFEPAK 35 LIFEPAK 35 is a clinically advanced device designed to promote improved cardiac care, enable clinical excellence and deliver in demanding situations. The device's advanced clinical decision support features and a large, user-friendly touchscreen offer a personalized clinical experience that lessens cognitive load at demanding times. The use of cutting-edge technology by emergency responders and healthcare professionals can assist expedite operations in their demanding, fast-paced workplac ...

Stryker Corporation (SYK) recently announced that it has entered into a definitive agreement to acquire Artelon, a privately held company specializing in innovative soft tissue fixation products for foot and ankle and sports medicine procedures. The acquisition will bolster Stryker's product line in the soft tissue fixation market and demonstrate the company's dedication to offering unique ligament and tendon reconstruction options. Price Performance For the past six months, SYK shares have rallied 17.4% co ...

PORTAGE, Mich., USA, June 4, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of LIFEPAK 35 monitor/defibrillator, the latest product in the monitor/defibrillator space, offering advanced technology and built on an intuitive1, modern platform to help advance patient care. LIFEPAK 35 Monitor/DefibrillatorLIFEPAK 35 Monitor/Defibrillator Emergency responders and healthcare professionals are facing unprecedented challenges and staff shortages. Seventy-five ...